Research suggests that grape seed extract and its proanthocyanidin compounds may have blood pressure-lowering effects, with a substantial body of preclinical evidence pointing to several plausible mechanisms, including enhanced nitric oxide production in blood vessel linings, reduced oxidative stress and inflammation, and suppression of proteins that cause blood vessels to constrict or thicken. Studies indicate that the majority of available evidence comes from animal models — including rat models of induced hypertension, diabetic kidney disease, pulmonary arterial hypertension, and metabolic syndrome — and from cell-based laboratory experiments, all of which reported generally favorable effects on blood pressure and related vascular markers. However, when the European Food Safety Authority reviewed the human clinical evidence, it found the results inconsistent across two intervention trials and concluded that a cause-and-effect relationship between grape seed extract and blood pressure maintenance in humans could not be established, with one trial showing benefit and another showing none. The overall picture is therefore one of mechanistically interesting preclinical findings that have not yet been reliably confirmed in human research, meaning the translation of animal and cell study results to meaningful blood pressure effects in people remains an open question.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| MegaNatural(®)-BP grape seed extract and maintenance of normal blood pressure... | Other | 2021 | Mixed | 72 |
| Vitis vinifera (grape) seed extract and resveratrol alleviate bisphenol-A-ind... | Other | 2019 | Supports | 67 |
| Grape seed proanthocyanidin extract alleviates ouabain-induced vascular remod... | Other | 2012 | Supports | 62 |
| Grape seed proanthocyanidin extracts enhance endothelial nitric oxide synthas... | Other | 2012 | Supports | 57 |
| Grape seed proanthocyanidin inhibits monocrotaline-induced pulmonary arterial... | Other | 2019 | Supports | 52 |
| Effects of grape seed proanthocyanidins extracts on AGEs and expression of bo... | Other | 2008 | Supports | 47 |
| Protective effects of grape seed proanthocyanidins on cardiovascular remodeli... | Other | 2015 | Supports | 42 |
| Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocro... | Other | 2018 | Supports | 37 |
| Cofilin1 is involved in hypertension-induced renal damage via the regulation ... | Other | 2015 | Supports | 32 |
| Gravinol ameliorates high-fructose-induced metabolic syndrome through regulat... | Other | 2008 | Supports | 27 |